Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 273 (TMEM273)
- Target
- TMEM273
- Molecular classification
- Integral membrane protein, transmembrane protein
01
Overview
Transmembrane protein 273 (TMEM273), also known as C10orf128, is an integral membrane protein encoded by the TMEM273 gene. Its precise molecular function is not well characterized. TMEM273 has been identified as part of a multi-gene signature predictive of prognosis and immune infiltration patterns in lung adenocarcinoma, but no direct targetable role, enzyme activity, receptor activity, or established interaction with therapeutic agents has been described. TMEM273 is not currently considered a therapeutic target, but its mRNA expression has been used as a biomarker in risk stratification models for cancer prognosis, especially in lung adenocarcinoma[2][3][5]. There is no evidence for direct involvement in drug response, specific mechanism of action, or notable safety concerns associated with targeting TMEM273. The gene is classified as an integral membrane protein mainly by predicted structure, with limited experimental functional characterization published to date.
- Other names
- TMEM273C10orf128Em:AC084727.5transmembrane protein 273
02
Biological functions
Prognostic indicator in lung adenocarcinoma risk modelsprecise function not well characterized
03
Disease associations
Cancer (specifically lung adenocarcinoma; included in prognostic models)no established mechanistic disease role reported
04
Biomarkers
TMEM273 (as part of a multi-gene risk model; used for prognosis in lung adenocarcinoma)
Beyond the preview
Go deeper on Transmembrane protein 273 (TMEM273).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Transmembrane protein 273 (TMEM273).